← Back to Search

Behavioral Intervention

Strength-Based Intervention for Autism

N/A
Recruiting
Led By Helen Genova, Ph. D.
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Lives in the United States of America Between the ages of 14-26 Speaks English well and at a 4th grade reading level
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-test
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if a program focused on building strengths can help young adults improve their job interview skills, especially those who struggle with interviews and want to get better at them."

Who is the study for?
This trial is for young adults aged 14-26 in the USA who have Autism or are on the Autism Spectrum and want to improve their job interview skills. Participants should speak English well and be able to read at a 4th grade level.
What is being tested?
The KF-STRIDE® program, a strength-based intervention designed to enhance job interview abilities in young adults with Autism, is being tested for its effectiveness in this study.
What are the potential side effects?
Since this trial involves an educational intervention rather than medication, traditional physical side effects are not applicable. However, participants may experience varying levels of stress or anxiety during practice interviews.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-test
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-test for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Employment Status
Global Assessment of Character Strengths (GACS)
Job Search Behavior Scale
+5 more
Secondary study objectives
Rosenberg Self-Esteem Scale (RSES)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
In this arm, participants would participate in in an intervention program that uses character strengths to improve job maintenance skills in young adults.
Group II: Control GroupActive Control1 Intervention
In this arm, participants are services as usual and will participate in their regular activities.

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
184 Previous Clinical Trials
11,239 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
86 Patients Enrolled for Autism Spectrum Disorder
Helen Genova, Ph. D.Principal InvestigatorKessler Foundation
2 Previous Clinical Trials
124 Total Patients Enrolled
~14 spots leftby Jun 2025